What is BPC-157?
A synthetic 15-amino-acid research peptide associated with gastric-peptide research. It is not presented here as a supplement.
What are the claimed benefits and what is actually supported?
Experimental work has investigated tissue repair and gastrointestinal models. Such findings do not establish equivalent human benefits.
What has BPC-157 been studied for?
Research includes tendon, ligament, muscle, bone and gastrointestinal injury models. See the evidence sections and linked studies above.
Is there human research on BPC-157?
Yes, but the published work is limited. Small observational studies and an ongoing trial must be distinguished from completed randomized evidence.
What are the known side effects and safety limitations?
The evidence does not establish reliable side-effect frequencies or long-term safety. Product-quality uncertainties add another limitation.
What is the difference between oral and injectable research?
Routes have different formulation and absorption questions. Robust human comparisons are lacking; neither route is recommended here.
What doses have been studied in research?
Protocols vary. The current trial record does not disclose a numeric dose amount. Research protocols should not be turned into self-administration instructions.
What is the half-life of BPC-157?
The cited animal study reports under 30 minutes. That figure is not a validated human half-life.
What is BPC-157 + TB-500 or the Wolverine Stack?
An informal name used for the combination. It is not an established treatment protocol.
Is BPC-157 banned in sport?
Yes. The 2026 WADA list explicitly names it under S0 and prohibits it at all times.
Why compare BPC-157 by price per mg?
It provides a consistent cost comparison across labelled pack quantities. It does not measure quality, purity, safety or effectiveness.
What does research use only mean?
The material is presented for research rather than human or veterinary consumption. The phrase itself is not a certification of quality or safety.